Financial Health Assessment: PI Global Limited

1. Financial Health Score: B-

Explanation: The patient has recovered from a near-fatal financial event in 2020 but still shows signs of vulnerability. While the current pulse (cash flow) is strong and the patient is generating retained earnings, there is significant "swelling" in short-term liabilities that requires monitoring. The historical volatility suggests a condition that is currently stable but requires ongoing management to prevent relapse.

2. Key Vital Signs

• Net Assets (Skeletal Strength): £62,340
  • Interpretation: The structural foundation is positive but lean. The patient has rebuilt its equity since the 2020 fracture (when net assets were negative £36,604), but the current equity base remains modest relative to the size of the balance sheet.
• Cash Position (Circulatory Health): £117,698
  • Interpretation: The lifeblood of the business is flowing well. Cash has tripled from £38,492 in 2024, indicating strong liquidity and an ability to meet immediate demands. This is a significant improvement from the dangerously low levels seen in 2017-2018.
• Current Ratio (Immune Response): 1.39
  • Interpretation: Calculated as Current Assets (£298,353) / Current Liabilities (£213,855). This is an adequate reading—above 1.0 means the company can cover its short-term debts—but it is below the ideal robust level of 1.5-2.0. The margin of safety is slim.
• Short-Term Creditors (Blood Pressure): £213,855
  • Interpretation: This figure has almost doubled from £114,551 in the previous year. This represents elevated "blood pressure." While the company has the cash to handle it, this sudden increase in pressure needs diagnosis—whether it is delayed supplier payments, tax liabilities, or accrued expenses.
• Retained Earnings (Nutritional Intake): £62,240
  • Interpretation: The patient is consuming more calories than it burns. The increase from £39,511 confirms the company is profitable, retaining approximately £22,729 of earnings in the business this year.

3. Diagnosis

Condition: Stable but under observation for acute liability swelling.

The financial history reveals a patient that went into shock in 2020, presenting with negative net assets (technical insolvency). However, through what appears to be a significant restructuring or capital injection (likely supported by the parent company, Packaging Innovation Limited), the patient was stabilised and admitted to rehabilitation in 2021-2022.

Currently, the diagnosis is Recovery with Complications. The core vitals—profitability and cash generation—are healthy. The company is generating cash and retaining earnings, which is the financial equivalent of a healing wound.

However, there is a distended abdomen in the form of current liabilities. The doubling of creditors due within one year (£114k to £213k) while long-term debt decreased (£77k to £49k) suggests the company may be shifting its debt profile from long-term to short-term, or it is stretching its trade payables to preserve cash. While the current cash (£117k) covers the immediate pressure, the ratio of total assets to total liabilities is tight (1.47), meaning the company lacks a deep financial reserve should another economic "illness" strike.

4. Recommendations

1. Monitor the Short-Term Swelling: The significant increase in short-term creditors needs immediate attention. Management should ensure this is managed trade credit rather than deferred expenses that cannot be met. A strategy to reduce current liabilities to a more comfortable level relative to current assets should be prioritised.
2. Strengthen the Balance Sheet Structure: While the move from negative equity to £62k is commendable, the financial buffers are thin. The company should aim to retain more earnings to build up its "muscle mass" (equity), reducing reliance on the parent company or external debt.
3. Maintain Cash Hygiene: The cash position has improved dramatically, but this was likely necessary to service the increased short-term liabilities. Do not view the cash pile as discretionary spending money; it is currently required to keep the circulatory system functioning given the high level of current creditors.
4. Review Long-Term Prognosis: The volatility from 2018 to 2025 (assets fluctuating from £5k to £700k) suggests the business model or revenue streams might be project-based or lumpy. Diversifying revenue streams to create a smoother, more predictable "heartbeat" would improve long-term resilience.